Literature DB >> 28088503

Evidence for splice transcript variants of TMEM165, a gene involved in CDG.

Marie-Ange Krzewinski-Recchi1, Sven Potelle2, Anne-Marie Mir2, Dorothée Vicogne2, Eudoxie Dulary2, Sandrine Duvet2, Willy Morelle2, Geoffroy de Bettignies2, François Foulquier2.   

Abstract

BACKGROUND: Defects in TMEM165 gene cause a type-II Congenital Disorder of Glycosylation affecting Golgi glycosylation processes. TMEM165 patients exhibit psychomotor retardation, important osteoporosis, scoliosis, irregular epiphyses and thin bone cortex. TMEM165 protein is highly conserved in evolution and belongs to the family of UPF0016 membrane proteins which could be an unique group of Ca2+/H+ antiporters regulating Ca2+ and pH homeostasis and mainly localized in the Golgi apparatus.
METHODS: RT-PCR from human brain tissues revealed TMEM165 splice-transcript variants. mRNA expression was analyzed by RT-Q-PCR. Expression plasmids allowed us to visualize isoform proteins and their subcellular localization. Their functions on glycosylation were achieved by looking at the gel mobility of highly glycosylated proteins in cells overexpressing isoforms.
RESULTS: In this study, we highlight, as previously shown for other ion channels, the existence of TMEM165 splice-transcripts isoforms, in particular the Short-Form (SF) and the Long-Form (LF) transcripts, leading to a 129 aa and 259 aa protein isoform, respectively. These proteins both localize in the endoplasmic reticulum and have different effects on glycosylation compared to the wild-type protein (324 aa). We also point out that the SF is expressed at low levels in all human cells and tissues checked, excepted in brain, and forms homodimer. The LF was only expressed in the temporal lobe of human brain. GENERAL SIGNIFICANCE: The finding of numerous splice variants could lead to a family of TMEM165 isoforms. This family of TMEM165 splice transcripts could participate in the fine regulation of TMEM165 isoforms' functions and localizations.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Congenital Disorders of Glycosylation; Golgi; N-glycosylation; Splice-transcript-isoforms; TMEM165

Mesh:

Substances:

Year:  2017        PMID: 28088503     DOI: 10.1016/j.bbagen.2017.01.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  2 in total

1.  H+ and Pi Byproducts of Glycosylation Affect Ca2+ Homeostasis and Are Retrieved from the Golgi Complex by Homologs of TMEM165 and XPR1.

Authors:  Nathan A Snyder; Christopher P Stefan; Camille T Soroudi; Adam Kim; Carlos Evangelista; Kyle W Cunningham
Journal:  G3 (Bethesda)       Date:  2017-12-04       Impact factor: 3.154

2.  TMEM165, a Golgi transmembrane protein, is a novel marker for hepatocellular carcinoma and its depletion impairs invasion activity.

Authors:  Jee-San Lee; Mi-Yeun Kim; Eun-Ran Park; Yan Nan Shen; Ju-Yeon Jeon; Eung-Ho Cho; Sun-Hoo Park; Chul Ju Han; Dong Wook Choi; Ja June Jang; Kyung-Suk Suh; Jungil Hong; Sang Bum Kim; Kee-Ho Lee
Journal:  Oncol Rep       Date:  2018-07-12       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.